The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteCAR T-cell Therapy Program
460 W 10th Ave., 5th Floor, BMT and Cell Therapy Suite
Columbus, , 43210
Columbus, , 43210
Website : https://cancer.osu.edu/cancer-specialties/cancer-care-and-treatment/clinical-services/blood-and-marrow-transplant-program
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Number performed | 74 | 68 | 83 | 110 | 141 |
Program Director
| Name | Phone |
|---|---|
| Marcos de Lima, MD |
Medical Director
| Name | Phone |
|---|---|
| Marcos de Lima, MD |
Physician
| Name | Phone |
|---|---|
| Gregory Behbehani, MD, PhD | |
| Don Benson, MD | |
| Bradley Blaser, MD | |
| David Bond, MD | |
| Jonathan Brammer, MD | |
| Naresh Bumma, MD | |
| Hannah Choe, MD | |
| Yun Choi, MD | |
| Beth Christian, MD | |
| Nathan Denlinger, DO, MS | |
| Srinivas Devarakonda, MD | |
| Abdullah Khan, MBBS | |
| Kami Maddocks, MD | |
| Sam Penza, MD | |
| Ashley Rosko, MD | |
| Yazeed Sawalha, MD | |
| Daniel Trotier, MD | |
| Elvira Umyarova, MD | |
| Sumithira Vasu, MBBS | |
| Timothy Voorhees, MD | |
| Sarah Wall, MD |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Aucatzyl (obecabtagene autoleucel, obe-cel )
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)